You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • AB0185 Nano-Emulsified Curcumin (NEC), a Patented Anti-Inflammatory Nutraceutical Compound Developed At Ohio State, Reduces Renal Pathology in an Animal Model of Lupus Nephritis

Citation Tools

Article menu
Download PDFPDF
Abstracts Accepted for Publication
SLE, Sjögren's and APS - etiology, pathogenesis and animal models
AB0185 Nano-Emulsified Curcumin (NEC), a Patented Anti-Inflammatory Nutraceutical Compound Developed At Ohio State, Reduces Renal Pathology in an Animal Model of Lupus Nephritis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Young N, Wu L, Gardner M, et al
AB0185 Nano-Emulsified Curcumin (NEC), a Patented Anti-Inflammatory Nutraceutical Compound Developed At Ohio State, Reduces Renal Pathology in an Animal Model of Lupus Nephritis
Annals of the Rheumatic Diseases 2015;74:952-953.